StockTipsArenaBeta

BUY Aurobindo Pharma — Arun Kumar Mantri

BUYAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

byArun Kumar MantriHorizon: BTST17 Sept 2026, 3:14 pm ISTvia CNBC Awaaz.

Entry₹1,684.1Inferred
Target₹1,705
Total upside +1.24% (call closed)
Stop loss₹1,670-0.84% risk
At expiry₹1,699.118 Sept 2026, 3:05 pm
Expired+0.89%
Follow Arun Kumar Mantri for new calls(18% target hit, 108 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 6 active BTST picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 18 Sept 2026
9 supporting0 opposing
Supports the BUY call (9)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·17 Sept · today

JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?

NewsEt-Markets·16 Sept · 2d ago

(opens in new tab)

Aurobindo Pharma Gets First USFDA Nod For First Metered-Dose Inhaler

NewsNdtv-Profit·15 Sept · 2d ago

(opens in new tab)

Aurobindo Pharma gets US FDA nod to sell first metered-dose asthma inhaler in US

NewsCnbc-Tv18·15 Sept · 3d ago

(opens in new tab)

Aurobindo Pharma received final US FDA approval for its Beclomethasone Dipropionate HFA Inhalation Aerosol in 40 mcg and 80 mcg strengths.

BSE · Company Update·15 Sept · 3d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Arun Kumar Mantri

Every call and its outcome